2018
$100M
from 15 investors over 15 rounds
LEXEO Therapeutics raised undisclosed on August 28, 2023
Investors: Sarepta Therapeutics
LEXEO Therapeutics raised $100M on September 9, 2021
Investors: Laurion Capital Management LP, Gray's Creek Capital Partners, Lundbeckfonden / Lundbeck Foundation, Omega Funds, Longitude Capital, Intus Capital, Woodline Partners LP and PBM Capital Group
LEXEO Therapeutics raised $85M on January 7, 2021
Investors: Lundbeckfonden / Lundbeck Foundation, Omega Funds, Woodline Partners LP, The Invus Group, PBM Capital Group and Longitude Capital